US Stocks Mixed Ahead of Key Inflation Data, Chip Sector Wobbles After China Sales Deal
PorAinvest
martes, 12 de agosto de 2025, 5:04 am ET1 min de lectura
OTEX--
Equities are down as investors await inflation data for hints on the Federal Reserve's move in September. A top official at the Federal Reserve, Michelle Bowman, expressed her belief that interest rates should be lower, which can help the economy but can also fuel inflation [2]. Bowman, who voted in favor of cutting interest rates, noted that the recent weaker-than-expected job market report strengthens her view that the Fed should cut interest rates three times this year [2].
Wall Street stocks are mixed, with the chip sector wobbling after a China sales deal. XOMA Royalty Corporation has completed the acquisition of Turnstone Biologics Corp. for a price per share of $0.34 in cash, plus a non-tradeable contingent value right [3]. Turnstone Biologics will become a wholly owned subsidiary of XOMA Royalty, and its shares will cease trading on Nasdaq and be delisted [3].
OpenText has appointed James McGourlay as interim CEO. McGourlay will succeed the outgoing CEO, who stepped down after a period of uncertainty and restructuring [4].
References:
[1] https://www.globenewswire.com/news-release/2025/08/11/3131361/0/en/McKinley-Acquisition-Corp-Announces-Pricing-of-150-Million-Initial-Public-Offering.html
[2] https://www.wqad.com/article/news/nation-world/federal-reserve-official-calls-for-rate-cuts/507-f7b2890d-1ae8-47fa-ac88-5f7ddc1ff11f
[3] https://www.globenewswire.com/news-release/2025/08/11/3130961/0/en/XOMA-Royalty-Announces-Closing-of-Tender-Offer-for-Turnstone-Biologics.html
[4] https://www.opentext.com/about-us/press-releases/opentext-appoints-james-mcgourlay-as-interim-ceo/
TSBX--
XOMA--
McKinley Acquisition has priced its $150 million initial public offering (IPO). Equities are down as investors await inflation data for hints on the Federal Reserve's move in September. Wall Street stocks are mixed, with the chip sector wobbling after a China sales deal. XOMA Royalty Corporation has completed the acquisition of Turnstone Biologics Corp. OpenText has appointed James McGourlay as interim CEO.
McKinley Acquisition Corporation (the “Company”) has priced its initial public offering (IPO) at $10.00 per unit, raising $150 million [1]. Each unit consists of one Class A ordinary share and one right, with each right entitling the holder to receive one-tenth (1/10) of one Class A ordinary share upon consummation of the Company’s initial business combination. The units are expected to trade on the Nasdaq Global Market under the symbol “MKLYU” beginning on August 12, 2025 [1].Equities are down as investors await inflation data for hints on the Federal Reserve's move in September. A top official at the Federal Reserve, Michelle Bowman, expressed her belief that interest rates should be lower, which can help the economy but can also fuel inflation [2]. Bowman, who voted in favor of cutting interest rates, noted that the recent weaker-than-expected job market report strengthens her view that the Fed should cut interest rates three times this year [2].
Wall Street stocks are mixed, with the chip sector wobbling after a China sales deal. XOMA Royalty Corporation has completed the acquisition of Turnstone Biologics Corp. for a price per share of $0.34 in cash, plus a non-tradeable contingent value right [3]. Turnstone Biologics will become a wholly owned subsidiary of XOMA Royalty, and its shares will cease trading on Nasdaq and be delisted [3].
OpenText has appointed James McGourlay as interim CEO. McGourlay will succeed the outgoing CEO, who stepped down after a period of uncertainty and restructuring [4].
References:
[1] https://www.globenewswire.com/news-release/2025/08/11/3131361/0/en/McKinley-Acquisition-Corp-Announces-Pricing-of-150-Million-Initial-Public-Offering.html
[2] https://www.wqad.com/article/news/nation-world/federal-reserve-official-calls-for-rate-cuts/507-f7b2890d-1ae8-47fa-ac88-5f7ddc1ff11f
[3] https://www.globenewswire.com/news-release/2025/08/11/3130961/0/en/XOMA-Royalty-Announces-Closing-of-Tender-Offer-for-Turnstone-Biologics.html
[4] https://www.opentext.com/about-us/press-releases/opentext-appoints-james-mcgourlay-as-interim-ceo/
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios